KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


BioPharm America™ 2017: Morphic Therapeutics finds new approach for reaching targets

Praveen Tipirneni is the CEO of Morphic Therapeutic in Waltham, Mass. The company uses a computational platform to help it better determine the dynamic nature of drug targets, sort of like watching "movies" of drug targets instead of just relying on still photographs. Speaking at BioPharm America™ in Boston, Tipirneni described the approach, and the opportunity it sees with making drugs against integrins, a tantalizing class of targets that has proven elusive to drugmakers in the past.

Get the latest news as it happens.